American Journal of Clinical and Experimental Immunology

Scope & Guideline

Advancing Immunology: Bridging Research and Clinical Practice

Introduction

Welcome to the American Journal of Clinical and Experimental Immunology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of American Journal of Clinical and Experimental Immunology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherE-CENTURY PUBLISHING CORP
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationAM J CLIN EXP IMMUNO / Am. J. Clin. Exp. Immunol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address40 WHITE OAKS LN, MADISON, WI 53711

Aims and Scopes

The American Journal of Clinical and Experimental Immunology focuses on advancing the understanding of immunological mechanisms and their clinical applications. The journal serves as a platform for disseminating research that bridges the gap between basic immunology and clinical practice.
  1. Clinical Immunology:
    The journal emphasizes studies that explore the immune system's role in various diseases, including cancer, autoimmune disorders, and infectious diseases, providing insights into potential therapeutic interventions.
  2. Translational Research:
    Research that translates basic immunological findings into clinical applications is a core focus, including studies on biomarkers, therapies, and technologies that can improve patient outcomes.
  3. Innovative Methodologies:
    The journal encourages the use of cutting-edge technologies and methodologies, such as single-cell sequencing and advanced imaging techniques, to deepen the understanding of immune responses.
  4. Interdisciplinary Approaches:
    The journal promotes research that integrates immunology with other fields, such as genetics, microbiology, and epidemiology, to provide a holistic view of health and disease.
  5. Public Health and Epidemiology:
    Studies that assess the impact of immune responses on public health issues, including vaccine efficacy and the immune response to infectious diseases, are a significant area of interest.
The American Journal of Clinical and Experimental Immunology has seen the emergence of several new themes that reflect current scientific priorities and societal needs. These trending topics highlight the journal's responsiveness to evolving challenges in immunology and public health.
  1. COVID-19 and Its Immunological Implications:
    Research on the immune response to SARS-CoV-2, including studies on long COVID, vaccine efficacy, and immune responses in specific populations, has surged, reflecting the global health crisis.
  2. Cancer Immunotherapy Advances:
    There is a growing focus on immunotherapy research, including the identification of biomarkers and immune cell profiling in cancer, which is critical for developing personalized treatment strategies.
  3. Role of Microbiome in Immunity:
    Emerging studies exploring the relationship between the microbiome and immune responses are gaining traction, highlighting how gut health can influence systemic immunity.
  4. Inflammation and Aging (Inflammaging):
    Research examining the links between chronic inflammation, aging, and immune senescence is increasingly prominent, as it has significant implications for public health and aging populations.
  5. Metabolomics in Immunology:
    The integration of metabolomics into immunological research is an emerging trend, as it offers insights into the metabolic states that influence immune responses and disease outcomes.

Declining or Waning

While the American Journal of Clinical and Experimental Immunology has several vibrant research areas, some themes appear to be declining in prominence over recent years. These waning scopes indicate a shift in research focus and funding priorities.
  1. Traditional Vaccine Research:
    Research focused solely on traditional vaccine technologies has seen a decline, possibly due to the emergence of novel vaccine platforms and a shift towards mRNA and vector-based vaccines.
  2. Basic Immunological Mechanisms without Clinical Relevance:
    Studies that delve into basic immunological mechanisms without a clear clinical application seem to be less favored, as the journal increasingly prioritizes translational research.
  3. Single Disease Focus:
    Research concentrating on single diseases is becoming less common, with a trend towards more integrative studies that consider multiple diseases and their interconnected immunological pathways.
  4. Descriptive Epidemiology:
    While epidemiological studies are still relevant, there is a noticeable decline in purely descriptive epidemiological research, with a preference for studies that link findings to immunological mechanisms or interventions.

Similar Journals

Immuno

Exploring the Frontiers of Immunology and Beyond
Publisher: MDPIISSN: Frequency: 4 issues/year

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

GENES AND IMMUNITY

Unraveling the Genetic Code of Immune Responses
Publisher: SPRINGERNATUREISSN: 1466-4879Frequency: 8 issues/year

GENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.

Turkish Journal of Immunology

Advancing Immunological Knowledge and Innovation
Publisher: GALENOS PUBL HOUSEISSN: 1301-109XFrequency: 3 issues/year

Turkish Journal of Immunology, published by GALENOS PUBL HOUSE, is a key platform for research in the field of immunology, with ISSN 1301-109X and E-ISSN 2147-8325. Established to foster the dissemination of original research, critical reviews, and cutting-edge developments, this journal spans a wide array of immunological topics, aiming to keep researchers, healthcare professionals, and students abreast of emergent trends and findings. Although classified in the Q4 quartile within both the Immunology and Allergy categories, the journal provides an essential venue for underrepresented research, paving the way for innovative ideas and collaborations. The editorial board emphasizes a rigorous peer-review process, ensuring the highest standards in the publication of quality science. For those keen to explore the intricacies of immunity, the Turkish Journal of Immunology is not to be missed.

JOURNAL OF IMMUNOLOGY

Elevating the Science of Immunology
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Cultivating Knowledge in the Evolving Field of Immunology
Publisher: WILEYISSN: 0300-9475Frequency: 12 issues/year

Scandinavian Journal of Immunology is a prestigious peer-reviewed journal published by Wiley, focused on the evolving field of immunology and its interdisciplinary ties with medicine. Since its inception in 1972, this journal has cultivated a rich repository of knowledge, showcasing innovative research and reviews that contribute to the understanding of immune system functions, disorders, and therapeutic interventions. With an impressive impact factor reflecting a Q2 ranking in Immunology and a top-tier Q1 status in miscellaneous Medicine categories for 2023, it is recognized for its high-quality scholarly output, positioning it among the leading journals in the field. Additionally, its Scopus ranking of #84 out of 236 in Immunology underscores its significance and relevance to both emerging and established researchers. Although it does not currently offer open access options, the journal’s expansive reach and rigorous publication standards make it an essential platform for disseminating impactful research to the global scientific community. The journal invites submissions that explore the complexities of the immune system, aiming to bridge clinical and basic science for a comprehensive understanding of immunological phenomena.

Immunological Medicine

Exploring the Frontiers of Immune Health
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 4 issues/year

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

Infektsiya i Immunitet

Exploring the frontiers of infection and immunity.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

CURRENT OPINION IN IMMUNOLOGY

Advancing the Frontiers of Immunological Research
Publisher: CURRENT BIOLOGY LTDISSN: 0952-7915Frequency: 6 issues/year

CURRENT OPINION IN IMMUNOLOGY is a prestigious journal dedicated to the dynamic field of immunology, published by CURRENT BIOLOGY LTD in the United Kingdom. With an ISSN of 0952-7915 and an E-ISSN of 1879-0372, this journal has been a cornerstone of scholarly communication since its inception in 1988 and continues to disseminate cutting-edge research and reviews aimed at advancing our understanding of immune responses. Holding a remarkable Q1 ranking in both Immunology and Allergy categories for 2023, it ranks impressively within the top percentiles in its field, securing 27th233 in Immunology and Allergy and 31st out of 236 in Immunology and Microbiology. Emphasizing high-impact research, the journal provides researchers, professionals, and students with valuable insights into emerging trends and critical developments. As a vital resource in immunological research, it serves as a platform for disseminating innovative findings, fostering collaboration, and enhancing scholarly exchange in a rapidly evolving scientific landscape.

AUTOIMMUNITY REVIEWS

Unveiling breakthroughs in autoimmune disorders.
Publisher: ELSEVIERISSN: 1568-9972Frequency: 8 issues/year

AUTOIMMUNITY REVIEWS is an esteemed journal in the field of immunology and allergy, published by Elsevier and located in the Netherlands. With a remarkable impact reflected in its Q1 category rankings for both Immunology and Allergy, this journal stands at the forefront of advancing research and knowledge in autoimmune diseases. Its Scopus rankings are particularly notable, placing it at #14 in the Immunology and Allergy category and #17 in the broader scope of Immunology and Microbiology, underscoring its influential role in the scientific community with a commendable 94th percentiles in both domains. Since its inception in 2002, AUTOIMMUNITY REVIEWS has provided a multidisciplinary platform for researchers and practitioners to share landmark studies, case reports, and reviews that propel the understanding of autoimmune disorders. Although it does not currently operate under an open-access model, the journal ensures rigorous peer review and high-quality publications, making it an essential resource for anyone looking to stay informed about the latest developments in autoimmune research.

CRITICAL REVIEWS IN IMMUNOLOGY

Connecting Ideas in the World of Immunology
Publisher: BEGELL HOUSE INCISSN: 1040-8401Frequency: 6 issues/year

CRITICAL REVIEWS IN IMMUNOLOGY, published by BEGELL HOUSE INC, is an essential journal in the field of immunology that has been contributing to the scientific discourse since 1980. With its ISSN 1040-8401 and E-ISSN 2162-6472, this journal provides a platform for critical analysis and comprehensive reviews that deepen understanding of immune responses and their implications in health and disease. Although currently categorized in the Q4 quartile for Immunology and Q3 for Immunology and Allergy, the journal's quality research and scholarly contributions are crucial for advancing knowledge within its fields—encompassing various aspects of innate and adaptive immunity. Researchers and professionals in immunology will find invaluable insights, aiding them in their quest for innovation and excellence, as the journal aims to foster interdisciplinary collaboration. While it does not operate on an open-access model, CRITICAL REVIEWS IN IMMUNOLOGY remains a significant resource for those dedicated to pushing the boundaries of immunology, with annual publications expected to last well into 2024 and beyond.